Everything below concerns evidence gap. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-12-31. Where a claim depends on a specific study, the study is described rather than over-claimed.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
| Property | Value | Notes |
|---|---|---|
| Origin | Fragment of a protein found in human gastric juice | Sequence corresponds to a fifteen-residue portion of the parent protein |
| Sequence | GEPPPGKPADDAGLV | Single linear chain, fifteen amino acids |
| Reported molecular weight | About 1419 daltons | Value quoted consistently in supplier and review literature |
| Regulatory status | Not an approved human medicine in the US or EU | Handled and sold as a research chemical |
| Sports status | Listed as prohibited | Falls under non-approved-substance categories in anti-doping codes |
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometers, a wavelength that captures the peptide backbone. The main peak area is reported as a percentage of total peak area, which serves as a conventional purity figure. Mass spectrometry provides an independent check on molecular mass and helps confirm the expected sequence. Additional tests may include amino acid analysis and water content determination. Results are only comparable when the same column, gradient, and detection settings are used.
Peptides are susceptible to hydrolysis, oxidation, and aggregation, and BPC-157 is no exception. The lyophilized powder form is generally more stable than a solution because residual moisture is low and molecular mobility is reduced. Once dissolved, the peptide is exposed to water, oxygen, and trace metal ions that accelerate degradation. Light exposure and repeated freeze-thaw cycles are also commonly cited as sources of loss. These general principles guide most handling recommendations found in supplier documentation.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Human data are far more limited than animal data. A small number of clinical reports exist, generally with few participants and without the randomization or blinding expected in later-phase trials. No large, independently replicated human trial has appeared in the indexed peer-reviewed literature. Statements about effects in people therefore rest on extrapolation from animal work rather than on direct evidence, and the strength of that extrapolation remains an open question rather than a settled matter.
Fatty acids are broken down to CO2 and water by the intra-cellular mitochondria through beta oxidation and the citric acid cycle. In the final step (oxidative phosphorylation), reactions with oxygen release a lot of energy, captured in the form of large quantities of ATP. Many cell types can use either glucose or fatty acids for this purpose, but fatty acids release more energy per gram. Fatty acids (provided either by ingestion or by drawing on triglycerides stored in fatty tissues) are distributed to cells to serve as a fuel for muscular contraction and general metabolism.
=== Transportation choices === Many members of Generation Z no longer view car ownership as a status symbol, a life milestone, or a ticket to freedom. However, large swaths of this cohort have not had a driver's license or owned a car because of their economic situation rather than their concerns for the environment or dislike of cars. Moreover, decades of auto-centric urban development in the United States have led to under-investment in walkable neighborhoods, bicycle lanes, and public transit. The number of Generation Z consumers taking out auto loans was rising drastically during the late 2010s. While a significant portion of Generation Z consider environmental friendliness to be an important factor, more than their predecessors when they were at the same age, affordability was much for important to them. Generation Z is not particularly concerned with style or brand; they are more interested in safety. They tend to be more receptive towards self-driving cars. They are also interested in the interior electronic technology of the cars they might purchase. More specifically, they would like to be able to hook up their smartphones to the Bluetooth-capable audio systems and backup cameras.
==== Absorption ==== Hydrocodone is only pharmaceutically available as an oral medication. It is well-absorbed, but the oral bioavailability of hydrocodone is only approximately 25%. The onset of action of hydrocodone via this route is 10 to 20 minutes, with a peak effect (Tmax) occurring at 30 to 60 minutes, and it has a duration of 4 to 8 hours. The FDA label for immediate-release hydrocodone with acetaminophen does not include any information on the influence of food on its absorption or other pharmacokinetics. Conversely, coadministration with a high-fat meal increases peak concentrations of different formulations of extended-release hydrocodone by 14 to 54%, whereas area-under-the-curve levels are not notably affected.
At 200–300 °C, if oxygen has not been excluded, the carbonaceous residue may start to burn, in a highly exothermic reaction, often with no or little visible flame. Once carbon combustion starts, the temperature rises spontaneously, turning the residue into a glowing ember and releasing carbon dioxide and/or monoxide. At this stage, some of the nitrogen still remaining in the residue may be oxidized into nitrogen oxides like NO2 and N2O3. Sulfur and other elements like chlorine and arsenic may be oxidized and volatilized at this stage. Once combustion of the carbonaceous residue is complete, a powdery or solid mineral residue (ash) is often left behind, consisting of inorganic oxidized materials of high melting point. Some of the ash may have left during combustion, entrained by the gases as fly ash or particulate emissions. Metals present in the original matter usually remain in the ash as oxides or carbonates, such as potash. Phosphorus, from materials such as bone, phospholipids, and nucleic acids, usually remains as phosphates.
The vacuum flask consists of two vessels, one placed within the other and joined at the neck. The gap between the two vessels is partially evacuated of air, creating a partial-vacuum which reduces heat conduction or convection. Heat transfer by thermal radiation may be minimized by silvering flask surfaces facing the gap but can become problematic if the flask's contents or surroundings are very hot; hence vacuum flasks usually hold contents below the boiling point of water. Most heat transfer occurs through the neck and opening of the flask, where there is no vacuum. Vacuum flasks are usually made of metal, borosilicate glass, foam or plastic and have their opening stoppered with cork or polyethylene plastic. Vacuum flasks are often used as insulated shipping containers. Extremely large or long vacuum flasks sometimes cannot fully support the inner flask from the neck alone, so additional support is provided by spacers between the interior and exterior shell. These spacers act as a thermal bridge and partially reduce the insulating properties of the flask around the area where the spacer contacts the interior surface. Several technological applications, such as NMR and MRI machines, rely on the use of double vacuum flasks. These flasks have two vacuum sections. The inner flask contains liquid helium and the outer flask contains liquid nitrogen, with one vacuum section in between. The loss of precious helium is limited in this way.
Sources: en.wikipedia.org
=== Separation Processes === King wrote the book Separation Processes in 1971. In the book, King presented that each of the separation processes (distillation, extraction, absorption, etc.) is a special case of a unified technology that can be described by a general set of quantitative principles. Before that, the standard separation operations were considered to be separate topics within the category of unit operations, with separate methodologies. The book was revised for a second edition in 1980. After the book went out of print, King secured the copyright back from McGraw-Hill and put it on eScholarship, where it is available open-access.
Lesbians are particularly targeted for gang rape. African lesbians are more likely to be raped as lesbians in the townships. To what extent are coloured lesbians also targeted for rape because of their sexual orientation? There are no statistics for this, and I don't know what percent of coloured lesbians are targeted for corrective rape action. Growing up, I never heard that lesbians were targeted in this way and so I want to know when that started happening. Gangsterism has always existed in the townships, so you can't attribute it to that. I don't know why black lesbians are targeted more, either. I'd like to know how many women are being raped by brothers, fathers, etc., in coloured townships. Why is no one studying this? Has it just been under-reported, not studied, or what? The United Nations UNAIDS 2015 Terminology Guidelines suggests that the term corrective rape should no longer be used, as it gives off the perception that something needs to be fixed. The guidelines propose that the term homophobic rape should be used instead. The words "so-called 'curative' or 'corrective' rape" were mentioned in 2011 in the first UN report on discrimination and violence against LGBTQ+ people. A 2013 global study on HIV/AIDS suggested the term lesphobic rape to emphasize the fact that lesbians constitute the overwhelming majority of victims of this phenomenon. Others have emphasized that other members of the LGBTQ community can also be victims of corrective rape for similar reasons.
probe-set A collection of two or more probes designed to measure a single molecular species, such as a collection of oligonucleotides designed to hybridize to various parts of the mRNA transcripts generated from a single gene.
He capped off his excellent clay court season by reaching his first major quarterfinal at the French Open. He needed to win three five-set matches to get that far before Thiem ended his run while he was faced with a hamstring injury. Up until the year-end championships, Zverev struggled to build on his early season success. He lost in the third round at both Wimbledon and the US Open, and his best result at the four remaining Masters events was a semifinal at the Shanghai Masters. He was able to defend his title at the Washington Open, his only title during this period. Zverev also reached two more doubles finals with his brother, but did not win either of them. At the end of the season, Zverev qualified for both the Next Generation Finals and the ATP Finals for the second consecutive year, again choosing to only compete at the latter event. He was placed in a group with Novak Djokovic, Marin Čilić, and John Isner. This year, Zverev was able to advance out of the group, only losing to No. 1 Djokovic in the round robin. He faced Federer in the semifinals and defeated him in straight sets to set up a rematch with Djokovic. Despite being a heavy underdog and having just lost to Djokovic earlier in the week, Zverev won the final in straight sets for the tenth and biggest title of his career. He became the youngest tour champion since Djokovic a decade earlier and the first German to win the season-ending championships since Boris Becker in 1995. This was also Zverev's first victory over a current world No. 1 player.
Rebellions in the former Cossack territories erupted occasionally during the interwar period. In 1920–1921, disgruntlement with continued Soviet grain-requisitioning activities provoked a series of revolts among Cossack and outlander communities in South Russia. The former Cossack territories of South Russia and the Urals also experienced a devastating famine in 1921–1922. In 1932–1933, another famine, known as the Holodomor, devastated Ukraine and some parts of South Russia, causing a population decline of about 20–30%. While urban areas were less affected, the decline was even higher in the rural areas, populated largely by Cossacks. Robert Conquest estimates the number of famine-related deaths in the Northern Caucasus at about one million. Government officials expropriated grain and other produce from rural Cossack families, leaving them to starve and die. Many families were forced from their homes in the severe winter and froze to death. Mikhail Sholokhov's letters to Joseph Stalin document the conditions and widespread deaths, as do eyewitness accounts. Besides starvation, the collectivization and dekulakization campaigns of the early 1930s threatened Cossacks with deportation to labor camps, or outright execution by Soviet security organs. In April 1936, the Soviet regime began to relax its restrictions on Cossacks, allowing them to serve openly in the Red Army. Two existing cavalry divisions were renamed as Cossack divisions, and three new Cossack cavalry divisions were established.
Sources: en.wikipedia.org
== Selected publications == Bounous, G; Molson, JH (2003). "The antioxidant system". Anticancer Research. 23 (2B): 1411–5. PMID 12820403. Kennedy, RS; Konok, GP; Bounous, G; Baruchel, S; Lee, TD (1995). "The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: A phase I-II clinical study". Anticancer Research. 15 (6B): 2643–9. PMID 8669840. Bounous, Gustavo; Somersall, Allan (April 1999). Breakthrough In Cell-Defense. GOLDENeight Publishing. ISBN 978-1-890412-86-9.
During the course of the symposium a semantic difficulty became apparent. To some of the participants, "microsomes" mean the ribonucleoprotein particles of the microsome fraction contaminated by other protein and lipid material; to others, the microsomes consist of protein and lipid contaminated by particles. The phrase "microsomal particles" does not seem adequate, and "ribonucleoprotein particles of the microsome fraction" is much too awkward. During the meeting, the word "ribosome" was suggested, which has a very satisfactory name and a pleasant sound. The present confusion would be eliminated if "ribosome" were adopted to designate ribonucleoprotein particles in sizes ranging from 35 to 100S. Albert Claude, Christian de Duve, and George Emil Palade were jointly awarded the Nobel Prize in Physiology or Medicine, in 1974, for the discovery of the ribosome. The Nobel Prize in Chemistry 2009 was awarded to Venkatraman Ramakrishnan, Thomas A. Steitz, and Ada E. Yonath for determining the detailed structure and mechanism of the ribosome.
The hill tribe people in Indochina were "hunted incessantly and carried off as slaves by the Siamese (Thai), the Anamites (Vietnamese), and the Cambodians". A Siamese military campaign in Laos in 1876 was described by a British observer as having been "transformed into slave-hunting raids on a large scale". The census, taken in 1879, showed that 6% of the population in the Malay sultanate of Perak were slaves. Enslaved people made up about two-thirds of the population in part of North Borneo in the 1880s.
== English proficiency == EF English Proficiency Index 2018: Ranked Thailand 64 of 88 nations (1=best, 80=worst). Other ASEAN nations ranked were Singapore, 3; Malaysia, 22; Philippines, 14; Vietnam, 41; Indonesia, 51; Myanmar, 82; and Cambodia, 85. EF English Proficiency Index 2017: Ranked Thailand 53 of 80 nations (1=best, 80=worst). Other ASEAN nations ranked were Singapore, 5; Malaysia, 13; Philippines, 15; Vietnam, 34; Indonesia, 39; Cambodia, 77; and Laos, 80. EF English Proficiency Index 2015: Thailand ranked 62 of 70 nations (1=best, 70=worst), classed in the "very low [English] proficiency" quintile. Other ASEAN nation ranked were: Singapore, 12; Malaysia, 14; Vietnam, 29; Indonesia, 32; Cambodia, 69. The top ranked country was Sweden, the lowest ranked country was Libya.
=== Early work === After completing her medical training in 1912, Lawrence briefly worked as a resident pathologist in Boston. That same year, she relocated to Portland, Oregon where she worked with tuberculosis specialist Ralph Matson. Lawrence established her own clinical laboratory in the Selling Building in 1913. She directed the laboratory for more than fifty years, providing diagnostic services to physicians and public agencies throughout Oregon. Lawrence conducted experimental work related to infectious disease and kept laboratory animals, including guinea pigs, at her home on Southeast Peacock Lane for research purposes.
Sources: en.wikipedia.org
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.
The peptide was named after a protein fraction found in human gastric juice, and the shorter form was called body protection compound. That phrase was shortened to the abbreviation BPC. The number 157 refers to a laboratory designation used in the original isolation work.
Its sequence corresponds to a segment of a protein present in gastric secretions, but the material supplied for research is made synthetically. No commercial product is purified from human or animal tissue. The synthetic route is used because it gives a defined chain length and a reproducible sequence.
It is a synthetic fifteen-amino-acid peptide whose sequence matches part of a protein found in human gastric juice. It is made by chemical synthesis, not purified from tissue. The name derives from an early fragment label, not from a molecular weight.